Healthtech and edtech are two of the fastest growing sectors, with the healthtech market size to reach $3.1 billion by 2033, while the global education technology market size is projected to reach $348.41 billion by 2030.
Each week will do a roundup of the top news, fundings, and IPOs from these two sectors.
Top News
- Royal Philips and WellSpan Health announced a seven-year strategic alliance that establishes a new research and innovation collaboration, including a research agreement and joint innovation strategy which will focus on validating the performance of new tools and technology. Research is expected to examine how AI and digital tools are improving throughput, cost and workflow efficiency, aimed at advancing WellSpan’s commitment to reclaim more than half a million hours of workforce time annually
- The Republic of Armenia’s Ministry of Education, Science, Culture and Sport, partnered with OpenAI and Firebird to expand access to frontier AI tools for 50,000 students, teachers, and researchers, making OpenAI’s AI tools, ChatGPT Edu and Codex, available to Armenia’s educational, engineering, and research communities alongside university faculty training programmes and research
AI News
- Elemeno Health, a provider of just-in-time microlearning solutions for frontline staff, partnered with Swisslog Healthcare, which integrates AI into hospital operations through automated material transport, robotic pharmacy dispensing, and smart inventory analytics, to support its suite of automation offerings in hospitals across North America
- K Health, a data-driven digital primary care system that uses AI to deliver personalized primary care services, partnered with the University of Pennsylvania Health System to deploy a suite of AI clinical agents across the health system’s electronic health record systems
- b.well Connected Health, a healthcare technology company unifying fragmented health data into AI-ready longitudinal records, and myTomorrows, a company that helps connect patients and physicians to all pre-approval treatments, partnered to improve how patients are connected to clinical trials
- Salesforce expanded its partnership with CVS Health to simplify and streamline call center interactions for members and providers with AI agents across multiple CVS Health businesses
- Thesis Care, an AI-powered care team platform for scalable clinical capacity, and Unio Health Partners, a differentiated multi-specialty physician services platform, partnered to deploy multiple Thesis AI care team agents across Unio’s practices
- Architect Financial Technologies, a multinational derivatives exchange group and electronic brokerage, acquired IMX Health, a futures and derivatives exchange dedicated specifically to the U.S. healthcare economy, to launch the American Innovation Exchange, an exchange for futures and options trading on compute costs tied to multiple GPU vendors and models, as well as other inputs in the artificial intelligence supply chain, pending regulatory review
- Pearson, an educational publishing and assessment company, announced new AI modules designed to help college and university students build practical, workforce-relevant AI skills within their field of study
- Debut, a biotech beauty company harnessing AI for science, and Natura, a beauty and personal care company, partnered to commercialize an AI-discovered longevity ingredient complex
- Imperial College London and Thomson Reuters launched The Thomson Reuters–Imperial Frontier AI Research Lab, a five-year partnership focused on foundational AI research spanning safety, reliability and societal impact
Really big financings:
Healthtech:
- NewLimit, a biotech company developing epigenetic therapies to extend human healthspan by reprogramming aging cells, raised a $435 million Series C led by Founders Fund alongside new investors Thrive Capital, Greenoaks, and Quiet Capital, and returning investors Kleiner Perkins, Abstract, Nat Friedman/Daniel Gross, Valor Equity Partners, Eli Lilly Ventures, Human Capital, and others
Big financings:
Healthtech:
- Contraline, a clinical-stage biopharmaceutical company developing novel male contraceptives, raised a $92.5 million Series B financing co-led by BVF Partners L.P. and RA Capital Management, with participation from GV, Lumira Ventures, Invus, and other new and existing investors
- Ona Therapeutics, a global biopharmaceutical company developing first-in-class antibody-drug conjugates to address treatment-resistant cancers, raised $86.6 million Series B financing in a round co-led by new investors Columbus Venture Partners and Mérieux Equity Partners, with participation from additional investors COFIDES and Korys, alongside all existing investors Alta Life Sciences, Asabys Partners, Bpifrance, as part of the InnoBio investment strategy, CDTI through SICC Innvierte, FundPlus NV and Ysios Capital
- CereVasc, a clinical-stage medical device company developing novel, minimally invasive treatments for neurological diseases, raised an $85 million Series C financing led by Piper Sandler Merchant Banking, with participation from Johnson & Johnson Innovation and Medtronic, along with existing investors Bain Capital Life Sciences and Perceptive Xontogeny Venture Funds
- Adaptive Innovations, an AI-native home health care provider, raised a $50 million Series A round led by Felicis, with participation from Bain Capital Ventures, Optum Ventures, Sunflower Capital, Conviction, BoxGroup, Dorm Room Fund and Constellation, as well as angel investors from OpenAI
- Semble, a healthcare technology company that develops practice management and health record software for private healthcare providers, raised a £30 million Series C funding round led by Revaia, with participation from a second new investor Partech, alongside continued backing from existing investors Mercia Ventures and Octopus Ventures
- IMU Biosciences, a biotechnology company decoding the immune system to pioneer a paradigm shift in how we understand, diagnose and treat disease, raised £40 million in a round co-led by IQ Capital and Molten Ventures, and supported by The British Business Bank and Meltwind alongside existing investors
- Subtle Medical, a provider of AI-powered medical imaging software, raised $33 million in growth capital, anchored by a Series C financing led by funds managed by Morgan Stanley Expansion Capital. The financing included participation from Shinhan Venture Investment and existing investors, Fusion Fund, EnvisionX, BRV, and Samsung Ventures
- Oak Hill Bio, a clinical-stage rare disease therapeutics company, raised a $32.5 million Series A round co-led by Balyasny Asset Management, venBio, and Janus Henderson Investors with participation from KCap Biotechnology Fund
- Advanced NanoTherapies, a clinical-stage medical device company dedicated to improving treatment outcomes for patients with coronary artery disease and peripheral artery disease, raised more than $31 million in a round co-led by an undisclosed strategic investor and S3 Ventures, with participation from the T45 fund as well as new and existing investors
- Mammogen, which specializes in improving the detection, diagnosis, and treatment of breast cancer, from end-to-never-end, raised a $30 million Series A from undisclosed investors
- Waypoint Bio, an AI-native biotech company using spatial biology to design next-generation CAR T therapies for solid tumors, raised a $20 million Series A financing round led by Amplify Partners. General Catalyst, Time BioVentures, Mitsui Global Investments, and Lux Capital participated in the round, alongside existing investors including Hummingbird Ventures
- Novellia, a real-world data company built entirely on information patients choose to contribute to medical research, raised an $18 million Series A led by Spark Capital with participation from Khosla Ventures, Acrew Capital, Bling Capital, and TMV
- Tavo Biotherapeutics, a company developing a pipeline of therapies targeting glaucoma and retinal disease, raised a $17 million Series A financing led by Pureos Bioventures with participation by Polaris Partners and continued support from existing investor Tau Capital
- Flok Health, which was regulatory approval to diagnose, treat and discharge patients with no clinician watching over the process, raised $12.5 million in a round led by AlbionVC, with existing backers Eka VC and Form Ventures and new investor Mercia Ventures
Not so big financings:
Healthtech:
- Biond Biologics, a private clinical-stage biotechnology company developing first-in-class immunotherapies for cancer and immune-mediated diseases, raised $8 million Guangzhou-Israel Biotechnology Fund
- Kalogon, a medical device company developing smart seating solutions, raised $5.75 million in a round led by Enable Ventures, with participation from Florida Opportunity Fund, Castellan Group and returning investors DeepWork Capital, Sawmill Angels and Black Opal
- Radley Health, a behavioral health company focused on serving adults living with serious mental illness, raised a $3 million seed funding round from Aurora Forge, Jackson Healthcare, Peg’s Foundation, and several prominent family offices. These new investors join CareSource, which previously announced an investment into Radley Health
- Moonlight AI, a company building image analysis software for clinical-grade diagnostics to turn routine blood and cytology imaging into genomic insights, raised a €2.8 million Seed funding round co-led by Lotus One Investment, VP Venture Partners, and MEDIN Fund. Additional participation came from N&V Capital and existing investor QAI Ventures
Policy and government
- The Centers for Medicare & Medicaid Services released an Interim Final Rule with Comment requiring that certain adult Medicaid applicants and enrollees must, as a condition of Medicaid eligibility, meet an 80 hours per month work requirement, through employment, education, work programs, or community service
- The American Academy of Physician Associates and the Physician Associates Education Association sued the Trump administration over a federal rule limiting student loan borrowing for some graduate degree programs that impact healthcare professionals, including physician associates and assistants, nurse practitioners and other clinical providers
Random news
- More than 100,000 live cockroaches illegal to keep in Australia were confiscated from a single breeder in the country’s largest-ever seizure of exotic invertebrates. The haul of Madagascar hissing cockroaches and dubia cockroaches, one of the world’s biggest cockroaches, measuring 2 to 3 inches in length, was worth 200,000 Australian dollars or $142,000
